242 related articles for article (PubMed ID: 25605456)
21. Codevelopment of genome-based therapeutics and companion diagnostics: insights from an Institute of Medicine roundtable.
McCormack RT; Armstrong J; Leonard D
JAMA; 2014 Apr; 311(14):1395-6. PubMed ID: 24522512
[No Abstract] [Full Text] [Related]
22. A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.
Luo D; Smith JA; Meadows NA; Schuh A; Manescu KE; Bure K; Davies B; Horne R; Kope M; DiGiusto DL; Brindley DA
Front Genet; 2015; 6():357. PubMed ID: 26858745
[TBL] [Abstract][Full Text] [Related]
23. US FDA and personalized medicine: in vitro diagnostic regulatory perspective.
Težak Ž; Kondratovich MV; Mansfield E
Per Med; 2010 Sep; 7(5):517-530. PubMed ID: 29776248
[TBL] [Abstract][Full Text] [Related]
24. Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics.
Tsourounis M; Stuart J; Pignato W; Toscani M; Barone J
Ther Innov Regul Sci; 2015 Jul; 49(4):530-543. PubMed ID: 30222427
[TBL] [Abstract][Full Text] [Related]
25. The Regulation of Companion Diagnostics: A Global Perspective.
Ansari M
Ther Innov Regul Sci; 2013 Jul; 47(4):405-415. PubMed ID: 30235516
[TBL] [Abstract][Full Text] [Related]
26. Current and future trends in biomarker discovery and development of companion diagnostics for arthritis.
Gibson DS; Bustard MJ; McGeough CM; Murray HA; Crockard MA; McDowell A; Blayney JK; Gardiner PV; Bjourson AJ
Expert Rev Mol Diagn; 2015 Feb; 15(2):219-34. PubMed ID: 25455156
[TBL] [Abstract][Full Text] [Related]
27. The biggest challenges currently facing companion diagnostic advancement.
Halim AB
Expert Rev Mol Diagn; 2014 Jan; 14(1):27-35. PubMed ID: 24308333
[TBL] [Abstract][Full Text] [Related]
28. [Companion diagnostics in the era of personalized medicine--chairmen's introductory remarks].
Fukutsuka K; Takubo T
Rinsho Byori; 2014 Apr; 62(4):378-80. PubMed ID: 25022067
[TBL] [Abstract][Full Text] [Related]
29. Systems biology meets -omic technologies: novel approaches to biomarker discovery and companion diagnostic development.
Caberlotto L; Lauria M
Expert Rev Mol Diagn; 2015 Feb; 15(2):255-65. PubMed ID: 25362968
[TBL] [Abstract][Full Text] [Related]
30. Companion Diagnostics and Molecular Imaging.
Puranik AD; Kulkarni HR; Baum RP
Cancer J; 2015; 21(3):213-7. PubMed ID: 26049701
[TBL] [Abstract][Full Text] [Related]
31. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
[TBL] [Abstract][Full Text] [Related]
32. Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics.
Batrla R; Jordan BW
Ann N Y Acad Sci; 2015 Jun; 1346(1):71-80. PubMed ID: 25866164
[TBL] [Abstract][Full Text] [Related]
33. FDA perspective on companion diagnostics: an evolving paradigm.
Mansfield EA
Clin Cancer Res; 2014 Mar; 20(6):1453-7. PubMed ID: 24634468
[TBL] [Abstract][Full Text] [Related]
34. Intellectual property considerations for molecular diagnostic development with emphasis on companion diagnostics.
Glorikian H; Warburg RJ; Moore K; Malinowski J
Expert Opin Ther Pat; 2018 Feb; 28(2):123-128. PubMed ID: 29224409
[TBL] [Abstract][Full Text] [Related]
35. Next-generation medicines: past regulatory experience and considerations for the future.
Pacanowski MA; Leptak C; Zineh I
Clin Pharmacol Ther; 2014 Mar; 95(3):247-9. PubMed ID: 24548989
[TBL] [Abstract][Full Text] [Related]
36. Summary of DIA Workshop on Co-Development of Personalized Medicine and In Vitro Diagnostic Companion Devices.
Kim LP; Stuart JN; Schultz D; Boiani JA
Ther Innov Regul Sci; 2013 May; 47(3):294-298. PubMed ID: 30231425
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacogenomics].
Nakatani K; Nobori T
Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
[TBL] [Abstract][Full Text] [Related]
38. The current landscape of the FDA approved companion diagnostics.
Jørgensen JT
Transl Oncol; 2021 Jun; 14(6):101063. PubMed ID: 33714919
[TBL] [Abstract][Full Text] [Related]
39. [Companion diagnostics and reimbursement system].
Tazawa Y
Rinsho Byori; 2013 May; 61(5):435-42. PubMed ID: 23947184
[TBL] [Abstract][Full Text] [Related]
40. Preface for companion diagnostics.
Carini C
Ann N Y Acad Sci; 2015 Jun; 1346(1):v-vi. PubMed ID: 26099691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
